Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,924.41 +4,019.03 (+6.82%) CMC Crypto 200
1,357.92 +80.94 (+6.33%)
Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.06B |
| Enterprise value | 6.22B |
| Trailing P/E | 18.96 |
| Forward P/E | 13.02 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.44 |
| Price/book (mrq) | 60.37 |
| Enterprise value/revenue | 7.50 |
| Enterprise value/EBITDA | 13.77 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.25 |
| 52-week change 3 | 28.45% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 45.00 |
| 52-week low 3 | 29.85 |
| 50-day moving average 3 | 39.98 |
| 200-day moving average 3 | 38.82 |
Share statistics
| Avg vol (3-month) 3 | 1M |
| Avg vol (10-day) 3 | 771.76k |
| Shares outstanding 5 | 127.05M |
| Implied shares outstanding 6 | 127.05M |
| Float 8 | 125.43M |
| % held by insiders 1 | 1.12% |
| % held by institutions 1 | 100.24% |
| Shares short (15 Apr 2024) 4 | 8.24M |
| Short ratio (15 Apr 2024) 4 | 8.73 |
| Short % of float (15 Apr 2024) 4 | 8.78% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.48% |
| Shares short (prior month 15 Mar 2024) 4 | 8.2M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 33.96% |
| Operating margin (ttm) | 45.01% |
Management effectiveness
| Return on assets (ttm) | 11.89% |
| Return on equity (ttm) | 222.07% |
Income statement
| Revenue (ttm) | 829.25M |
| Revenue per share (ttm) | 6.29 |
| Quarterly revenue growth (yoy) | 26.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 416.93M |
| Net income avi to common (ttm) | 281.59M |
| Diluted EPS (ttm) | 2.10 |
| Quarterly earnings growth (yoy) | 48.00% |
Balance sheet
| Total cash (mrq) | 336M |
| Total cash per share (mrq) | 2.65 |
| Total debt (mrq) | 1.53B |
| Total debt/equity (mrq) | 1,827.33% |
| Current ratio (mrq) | 6.64 |
| Book value per share (mrq) | 0.66 |
Cash flow statement
| Operating cash flow (ttm) | 388.57M |
| Levered free cash flow (ttm) | 268.16M |
© 2024 Yahoo. All rights reserved.